📰 Clinical Development Programs News
Clinical Development Programs News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Development Programs. Real-time updates on events, politics, business and more.
July 16, 2024
Welcome to the to todays hearing. Pursuant house rules, some members will appear inperson and others will appear remotely via webex. Some members are appearing in person, let me first remind everyone that pursuant to the latest guidance from the house attending physician, all individuals attending this hearing in person must wear a face mask unless they are speaking. Members who are not wearing a facemask will not be recognized. Let me also make a few reminders to those members appearing in pers...
July 16, 2024
Ceos testify on Prescription Drug pricing. Members question why the retail price of their drugs frequently increases and at a rate that far exceeds inflation among other issues. This is just under 4 hours. Welcome to the to todays hearing. Pursuant house rules, some members will appear inperson and others will appear remotely via webex. Some members are appearing in person, let me first remind everyone that pursuant to the latest guidance from the house attending physician, all individuals atten...
July 7, 2024
Time and i want to make sure that we have just think our panelists and prepare for our next panel which is terrific and pleasing run join me in thanking the panel. [applause] [applause] [background sounds]. Will come up we will move on to her second panel. Im very excited is actually i want to say that i have a good friend doctor Janet Woodcock sue is the Principal Deputy commissioner has been at the fda for a number of years and is helped reorganize and restructure offices and centers. And is p...
June 4, 2024
Company Exploring Alternative Value Creation Opportunities Convertible note for $500,000.00 USD, Short-term Debt Reduced and Balance Sheet Strengthened to Prepare the Company for Long Term Funding...
February 28, 2024
Avidity Biosciences, Inc. , a biopharmaceutical company...
February 23, 2024
Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Earnings Call Transcript February 22, 2024 Vir Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.86, expectations were $-1.14. Vir Biotechnology, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello. Welcome to Vir […]
January 11, 2024
ConcertAI Highlights 2024 Partnerships, Strategy, Business Results, and AI Roadmap at 42nd Annual J.P. Morgan Healthcare Conference
January 11, 2024
Introduced CARA™, the predictive and generative AI Platform powered by multi-modal Real-World Data, enabling precision oncology, accelerating clinical trials, increasing patient access, driving improved patient
November 6, 2023
• Strategic Collaboration and Investment Agreements signed with AstraZenecaUpdated results of the Phase I BALLI-01 Trial evaluating UCART22 in r/...
August 8, 2023
/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced significantly improved financial results...